Government ❯ Regulatory Agencies ❯ FDA

Vaccine Approval Process

Public Health Policy Clinical Trials Emergency Use Authorization Safety Signals Public Health Regulations Policy Changes Vaccine Safety Monitoring Scientific Standards mRNA Vaccines Public Health Recommendations Postmarketing Surveillance COVID-19 Vaccine Distribution

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

FDA Refuses to File Moderna’s mRNA Flu Vaccine Application Over Trial Comparator

Former FDA Chiefs Rebuke Leaked Memo Claiming COVID Shots Killed 10 Children, Warn of Risky Vaccine Overhaul